MAPT and Alzheimer disease: Modulating both pathways rescued the neurodegenerative phenotype associated with AD and FTDP models which supports our two‐hit model where the absence of either aging‐induced metabolic dysfunction or Syn/Tau‐induced metabolic deficits would likely alleviate the disease‐associated pathological manifestations.